上半年，经济增长出现超预期下滑，在此背景下，医药行业产销增速有所回落。进入三季度后，在政府推出一系列“微刺激”政策的引导下，经济增长小幅回升，医药行业发展环境有所改善，整体发展增速有所回升。其中，前三季度，医药制造业工业增加值增速为13.5%，比上年同期下降1.1 个百分点，比上半年上升0.7 个百分点。                                

报告从政策环境、市场行情、厂商动态、科技研发、国际资讯、行业数据、分析评论等几个方面进行了分析评论。

2013年1-10月，医药行业运行呈现以下特点：一是受GMP稳步推进、GSP实施以及节能减排力度加大等因素影响，投资增速保持在30%以上，但增长势头有所放缓；二是随着“稳增长”政策的出台，增加值增长率和中西药品零售额增速双手止降转升；三是出口额增速低位恢复，进口额进入相对平稳的增长轨道；四是随着药品降价政策的影响逐渐消融，价格总体稳中略升；五是受医保支出和投资收益增速放缓影响，医药行业收入、利润、主营业务利润增速均有所回落。

Biophotonics refers to the science of generating and utilizing photons to image and identify biological molecules. This area of scientific research uses light and other forms of radiant energy to identify the functioning of inner cells and tissues in living organisms. The major applications of biophotonics include medical imaging and in vitro diagnostics. Biophotonics is extensively used in applications of oncology, dermatology, ophthalmology, surgery, and cardiology.The Global Biophotonics market is expected to grow at a steady pace during the period 2012-2016. The market was dominated by the Americas in 2012, followed by the EMEA and APAC regions. Currently, a major part of the market growth is derived from the Medical Diagnostics segment. Other segments such as Medical Therapeutics, Non-Medical Applications, and Tests and Components are expected to make significant contributions to the revenue of the overall market in the next few years. The Global Biophotonics market will witness an increase in competition due to low entry barriers. The Global Biophotonics market is expected to post a CAGR of 10.03 percent during the forecast period.

Radiopharmaceuticals are radioactive substances that are used for diagnosis or therapy purposes. These are made up of two components: a radioactive isotope that can be injected safely into the body, and a carrier molecule that delivers the isotope to the area to be treated or examined. Radiopharmaceuticals set out radiation, mostly in the form of alpha and beta particles, and target the affected areas. The dosages of radiopharmaceuticals that are used to diagnose medical problems vary, depending on the type of diagnosis. When radiopharmaceuticals are injected into the body, they emit radiation that can be traced with special cameras or computers. Radiopharmaceuticals find a major application in the field of oncology. Radiopharmaceuticals used in cancer treatment are small and simple substances, containing a radioactive isotope, and target specific areas of the body where cancer is present.

The emerging market for pharmaceutical products is termed as pharmerging. The Global Pharmaceutical market is witnessing a paradigm shift in the marketing of pharmaceutical products from the saturated developed regions to the developing regions, owing to an increased accessibility toward quality healthcare infrastructure supported by funds and investment from the government and private companies. These developing regions are referred to as the Pharmerging markets. Further, big pharmaceutical manufacturers are currently facing a decline in the sales of their products owing to a patent cliff leading to tough competition from generic drug manufacturers. As of 2012, the Pharmerging markets represent 20 percent of the Global Pharmaceutical market and are expected to represent 50 percent of the Global Pharmaceutical market by 2020.

The Global Cosmeceuticals market is expected to witness steady growth during the period 2012-2016. This industry is also forecast to be the fastest growing division of the Personal Care industry. The Global Cosmeceuticals market was dominated by Europe, followed by North America and ROW in 2012. The Hair Care and Skin Care segments are the key contributors to the revenue of this market. The overall market is expected to grow at a CAGR of 7.28 percent during the forecast period.

Packaging of products is a process of enclosing or protecting products for the purpose of their distribution, storage, sale, and use. It is useful for advertising a product, for protecting against damage during transportation, for persuading any possible buyer as well as to provide the product with an authentic identity. Healthcare products such as pharmaceuticals and medical devices require packaging so they can be safely transported, to maintain sterility, and to prevent breakage or spillage and contamination. Raw materials used for packaging healthcare products include plastic, glass, metal, and paper-based materials.The increasing aging population is leading to a growing demand for pharmaceuticals and medical devices. Hence, the Global Healthcare Packaging market is growing at a steady rate. The Americas dominated the market in 2012, which was followed by the EMEA region and the APAC region. The US, which accounted for the world's highest per capita healthcare expenditure, was the leading revenue contributor in the Healthcare Packaging market in the Americas in 2012. The market is expected to grow at a CAGR of 7.0 percent during the period 2012-2016.

MicroRNAs are a category of non-coding RNAs, which are single-stranded and short molecules, comprising approximately 22 nucleotides. They play an important role in the regulation of gene expression by interacting with mRNA molecules and suppressing protein synthesis, thereby resulting in a phenomenon called gene silencing. Each microRNA strand regulates the expression of several genes, thereby coordinating cellular pathways. Through such coordination, microRNAs guide activities such as cellular growth and proliferation, embryonic development, immune response, apoptosis, and stem cell differentiation. The unregulated growth of microRNAs leads to disruption of cellular pathways, thereby resulting in diseases such as cancer. However, over the years, research has indicated that the introduction of specific microRNAs into diseased cells can bring about a therapeutic response. This has led to the growth of the Global MicroRNA market owing to the discovery of microRNA use for therapeutic purposes and the development of microRNA-based tools, reagents, diagnostics, and therapeutics.

Compression therapy is one of the most essential methods in the treatment of venous disorders that help to decrease oedema and increase blood circulation. The Global Compression Therapy market is a rapidly growing market. It is an organized market and provides a huge growth opportunity for its vendors. The market has been witnessing new developments and technologies every year. The US contributes the largest share of the Global Compression Therapy market. It is estimated that the Global Compression Therapy market will grow at 5.11 percent CAGR during the forecast period.

The Global Electrosurgical Devices market is one of the major markets in the Global Surgical Equipment market and is witnessing continuous developments and innovations. The Americas generates the highest revenue in the Global Electrosurgical Devices market and is followed by the EMEA region. There is a vast opportunity for the market to grow significantly in certain countries in the APAC region such as Japan, India, and China. Moreover, the market in developing countries is expected to grow faster than in other geographies, which may lead to an increase in sales of new surgical products. It is estimated that the Global Electrosurgical Devices market will grow at a CAGR of 5.45 percent during the forecast period.

The healthcare system in Australia is quite a robust model which lays focus on health as well as social well-being. Healthcare in the country is provided majorly by the public sector, followed by the private sector.